These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28782785)

  • 21. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
    Koutsaki M; Spandidos DA; Zaravinos A
    Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.
    Son SW; Lee HY; Moeng S; Kuh HJ; Choi SY; Park JK
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of microRNA nuclear transport in human cancer.
    Melo SA; Esteller M
    Semin Cancer Biol; 2014 Aug; 27():46-51. PubMed ID: 24607282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of miR-21 in Cancer.
    Pfeffer SR; Yang CH; Pfeffer LM
    Drug Dev Res; 2015 Sep; 76(6):270-7. PubMed ID: 26082192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA and cancer--a brief overview.
    Acunzo M; Romano G; Wernicke D; Croce CM
    Adv Biol Regul; 2015 Jan; 57():1-9. PubMed ID: 25294678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA regulation of F-box proteins and its role in cancer.
    Wu ZH; Pfeffer LM
    Semin Cancer Biol; 2016 Feb; 36():80-7. PubMed ID: 26433073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
    Chen SY; Teng SC; Cheng TH; Wu KJ
    Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of phytochemicals in the inhibition of epithelial-mesenchymal transition in cancer metastasis.
    Kim EK; Choi EJ; Debnath T
    Food Funct; 2016 Sep; 7(9):3677-85. PubMed ID: 27507108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implication of microRNAs in drug resistance for designing novel cancer therapy.
    Sarkar FH; Li Y; Wang Z; Kong D; Ali S
    Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flavonoid display ability to target microRNAs in cancer pathogenesis.
    Singh S; Raza W; Parveen S; Meena A; Luqman S
    Biochem Pharmacol; 2021 Jul; 189():114409. PubMed ID: 33428895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
    Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
    BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs in tumorigenesis.
    Skaftnesmo KO; Prestegarden L; Micklem DR; Lorens JB
    Curr Pharm Biotechnol; 2007 Dec; 8(6):320-5. PubMed ID: 18289039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of microRNA-410 in molecular oncology: A double edged sword.
    Wen R; Umeano AC; Essegian DJ; Sabitaliyevich UY; Wang K; Farooqi AA
    J Cell Biochem; 2018 Nov; 119(11):8737-8742. PubMed ID: 30086210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulation of microRNA biogenesis and gene silencing in cancer.
    Hata A; Lieberman J
    Sci Signal; 2015 Mar; 8(368):re3. PubMed ID: 25783160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence.
    Paskeh MDA; Mirzaei S; Orouei S; Zabolian A; Saleki H; Azami N; Hushmandi K; Baradaran B; Hashmi M; Aref AR; Ertas YN; Zarrabi A; Ashrafizadeh M; Samarghandian S
    Int J Biol Macromol; 2021 Nov; 191():727-737. PubMed ID: 34562537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of epithelial-to-mesenchymal cancerous transition by natural products.
    Zhang L; Wang X; Lai M
    Fitoterapia; 2015 Oct; 106():247-55. PubMed ID: 26386389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs: master regulators of drug resistance, stemness, and metastasis.
    Raza U; Zhang JD; Sahin O
    J Mol Med (Berl); 2014 Apr; 92(4):321-36. PubMed ID: 24509937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of microRNAs for potential cancer therapeutics.
    Wu W
    Methods Mol Biol; 2011; 676():59-70. PubMed ID: 20931390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.
    O'Bryan S; Dong S; Mathis JM; Alahari SK
    Eur J Cancer; 2017 Feb; 72():1-11. PubMed ID: 27997852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of cancer metastasis by microRNAs.
    Chan SH; Wang LH
    J Biomed Sci; 2015 Jan; 22(1):9. PubMed ID: 25614041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.